Hydroxymethyl substituted dihydroisoxazole derivatives useful as antibiotic agents

Details for Australian Patent Application No. 2004218206 (hide)

Owner AstraZeneca AB

Inventors Carcanague, Daniel Robert; Gravestock, Michael Barry; Hales, Neil James

Agent Davies Collison Cave

Pub. Number AU-A-2004218206

PCT Pub. Number WO2004/078753

Priority 0304723.0 01.03.03 GB; 0318607.9 08.08.03 GB

Filing date 24 February 2004

Wipo publication date 16 September 2004

International Classifications

C07D 413/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 031/4427 - containing further heterocyclic ring systems

A61P 031/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/078753 Priority application(s): WO2004/078753

31 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004218207-Method for producing long-chain hydrocarbons from natural gas

2004218203-Interior safety capsules